Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

74,007.70

Todday's Low

73,181.90

Open at

73,268.47

Previous Close

73,246.03

Volumes

0.00

Avg Price

707.07

Historical Performance

News

09 Oct 26
Brooks Laboratories Limited confirms regulatory compliance for the quarter ended September 30
Brooks Laboratories Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Ltd.
17 Aug 26
Brooks Laboratories Limited announced a book closure from August 27 to September 3, 2026
Brooks Laboratories Limited informed the BSE Limited and National Stock Exchange of India Ltd.
06 Aug 26
Brooks Laboratories to review quarterly results at board meeting on August 13, 2026
Brooks Laboratories Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report from the statutory auditors.
12 Jun 26
Brooks Laboratories AGM scheduled
Brooks Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2026.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
28-10-26 59.55 61.42 58.93 59.90 23697 658 1423037.01 22698.85
27-10-26 57.02 60.30 57.02 59.72 24757 762 1473662.58 22749.75
26-10-26 59.90 60.94 55.50 57.86 53859 895 3169119.22 22753.20
23-10-26 61.25 62.89 56.70 57.86 99200 2011 5737326.84 22600.00
22-10-26 60.20 64.29 59.10 61.09 54438 1231 3387005.20 22687.65
21-10-26 65.07 65.27 60.00 60.78 74347 1158 4645117.18 22811.35
19-10-26 66.75 69.40 64.50 65.07 47904 680 3185904.56 22888.95
16-10-26 70.06 72.50 66.55 67.57 122176 1482 8434278.87 23146.15
15-10-26 69.15 73.40 68.56 70.42 294417 2632 20962577.12 22997.35
14-10-26 67.80 71.70 65.46 68.72 215139 1829 14736751.62 22622.70

Fundamentals

Company Valuation

Market Cap (₹cr)

176.74

PE Ratio

38.71

PB Ratio

1.46

Dividend Yield

0

ROE

3.96

ROCE

4.25

Book Value (₹)

41.0235362

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15500292 52.62 15500292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15500292 52.62 15500292 8
Total ShareHolding for Promoter & Group 15500292 52.62 15500292 8
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12098 0.04 12098 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2916111 9.90 2916111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 177698 0.60 177698 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3105907 10.54 3105907 5
plus  Non Institution
Bodies Corporate 978708 3.32 978708 63
Clearing Members 68022 0.23 68022 15
Directors & their Relatives 100 0.00 100 1
Employees 1865 0.01 537 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 276201 0.94 276201 146
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 408100 1.39 408100 251
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3622523 12.30 3622523 65
Individuals holding nominal share capital up to Rs. 1 lakh 5455769 18.52 5455397 10683
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 10 0.00 10 1
Sub Total 10851049 36.84 10849349 11240
Total Public Shareholding 13956956 47.38 13955256 11245
Total of Promoter & Public ShareHolding 29457248 100.00 29455548 11253
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 29457248 100.00 29455548 11253

Financials (₹ in cr)

Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales85.7482.5679.4963.2091.18
OPM (%)28.67-11.86-24.62-61.27-26.21
OP24.58-9.79-19.57-38.73-23.90
Other Income1.170.880.920.210.80
PBIDT27.01-7.16-16.95-29.16-13.45
INTEREST0.841.030.842.183.10
PBDT26.17-8.19-17.79-31.34-16.55
PBT24.58-9.79-19.57-38.01-23.90
EO0.000.000.000.360.00
PBT after EO24.58-9.79-19.57-38.37-23.90
TAXES0.000.180.03-7.32-4.59
PAT24.58-9.97-19.59-20.89-11.29
EPS8.35-3.72-7.67-12.57-7.82
Raw Material57.8663.2856.2665.7369.02
Power and Fuel2.602.282.185.124.37
Employee Cost17.6815.7013.2627.4421.00
Other Manufacturing Expenses0.400.390.331.141.84
Selling and Administration Expenses6.185.324.537.706.88
Miscellaneous Expenses1.501.091.309.804.62
Revenue (Growth %) 3.853.8625.76-30.6918.04
PBIDT (Growth %)-477.12-57.74-41.88116.80-1,177.38
PAT (Growth %) -346.65-49.13-6.2285.05-41.73
PBIDT (Margin %)31.50-8.67-21.32-46.14-14.75
PAT (Margin %) 28.67-12.07-24.65-33.05-12.38

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 29.4629.4626.2524.7024.7024.70
Reserves Total 91.3985.6143.2832.0840.3039.51
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds120.85115.0769.5356.7865.0064.21
Secured Loans 7.286.065.045.664.928.40
Unsecured Loans 1.241.520.600.851.050.00
Total Debt8.527.585.646.515.978.40
Other Liabilities1.601.381.462.022.141.76
Total Liabilities130.97124.0376.6365.3173.1174.37
APPLICATION OF FUNDS :
Gross Block 26.0025.1523.2722.8321.0719.64
Less : Accumulated Depreciation 11.4811.179.607.835.934.68
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 14.5213.9813.6715.0015.1414.96
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress1.190.000.000.001.120.02
Producing Properties0.000.000.000.000.000.00
Investments 90.5390.5246.8646.8546.8446.81
Current Assets, Loans & Advances
Inventories 11.029.209.6111.3016.5912.38
Sundry Debtors 16.1119.9916.3212.7515.039.59
Cash and Bank Balance7.551.250.691.081.080.88
Loans and Advances 2.733.434.432.474.342.49
Total Current Assets37.4233.8831.0527.6137.0425.34
Less : Current Liabilities and Provisions
Current Liabilities 14.2115.6817.1225.7929.6118.00
Provisions 1.190.950.641.320.740.63
Total Current Liabilities & Provisions15.4016.6317.7627.1130.3418.63
Net Current Assets22.0217.2513.290.506.696.71
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability0.000.000.000.000.000.00
Net Deferred Tax0.000.000.000.000.000.00
Other Assets2.712.282.812.963.325.87
Total Assets130.97124.0376.6365.3273.1174.37
Contingent Liabilities122.9475.6870.7919.7624.1120.78

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -4.23-0.219.7242.430.17
Investing Activities 1.12-0.400.18-45.14-2.92
Net Cash Flow 0.02-0.060.10-0.086.54
Operating Activities 3.120.55-9.802.639.29

Peers

Aarti Pharmalabs...

911.00

(+3.29%)
Accent Microcell...

635.05

(+2.22%)
Accretion Pharma...

181.00

(-2.16%)
Achyut Healthcar...

Advanced Enzyme ...

263.75

(+1.54%)
Akums Drugs & Ph...

740.00

(+2.39%)
Albert David Ltd

777.60

(+0.73%)
Alembic Pharmace...

792.60

(+1.25%)

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Functional Directors
DSM
Durga Sankar Maity
E D & Wholetime Director
Dir.
BSR
Bhushan Singh Rana
E D & Wholetime Director
Dir.
JPS
Jitendra Pratap Singh
E D & Wholetime Director
Dir.
Independent Directors
US
Usha Singh
Independent Non Exe. Director
Ind.
LM
Lalit Mahajan
Independent Non Exe. Director
Ind.
MM
Manav Mahajan
Independent Non Exe. Director
Ind.

Frequently Asked Questions

What is the NSE symbol and BSE code for Brooks Laboratories Ltd? −

Brooks Laboratories Ltd trades on NSE under BROOKS and on BSE under code 533543. The ISIN is INE650L01011 and the face value is Rs 10.

What is the share price of Brooks Laboratories Ltd today? +

As of 29 October 2026, Brooks Laboratories Ltd trades at Rs 63.08, a change of 3.18 (5.31%) on the day. Prices are live and subject to change.

What is the market capitalisation of Brooks Laboratories Ltd? +

As of 29 October 2026, Brooks Laboratories Ltd has a market cap of about Rs 176.74 crore. This figure is live and moves with the share price.

Is Brooks Laboratories Ltd profitable? +

In March 2026, Brooks Laboratories Ltd reported a profit after tax of Rs 24.58 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Brooks Laboratories Ltd? +

: As of 29 October 2026, the PE (TTM) for Brooks Laboratories Ltd is 38.71 and the price-to-book ratio is 1.46. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Brooks Laboratories Ltd pay a dividend? +

As of 29 October 2026, the dividend yield for Brooks Laboratories Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Brooks Laboratories Ltd? +

As of the latest disclosed pattern, promoters hold 52.62% of Brooks Laboratories Ltd. Public shareholding is 47.38%, including mutual funds at 9.90% and foreign institutional investors at 0.04%.

What were the latest annual financials of Brooks Laboratories Ltd? +

In March 2026, Brooks Laboratories Ltd reported net sales of Rs 85.74 crore, revenue growth of 3.85%, and earnings per share of Rs 8.35.